Products |

Advantage-MR EP Recorder/Stimulator System

Related Content

Orchestra BioMed Receives FDA Breakthrough Device Designation
News | EP Lab
Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy

April 22, 2025 — Orchestra BioMed Holdings, a biomedical company accelerating high-impact technologies to patients ...

Home April 29, 2025
Home
News | EP Lab
Stereotaxis to Demo GenesisX Robotic System at HRS

April 21, 2025 — Stereotaxis, a provider of surgical robotics for minimally invasive endovascular intervention, will ...

Home April 21, 2025
Home
News | EP Lab
Data Demonstrates Favorable Impact of AVIM Therapy on Diastolic Dysfunction

Feb. 12, 2025 — Orchestra BioMed Holdings, a biomedical company accelerating high-impact technologies to patients ...

Home February 14, 2025
Home
BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, reported it has submitted a 510(k) for approval of its patented Morph DNA Steerable Introducer Sheath
News | EP Lab
BioCardia Submits for FDA Approval of Morph DNA Steerable Introducer Product Family

July 31, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home July 31, 2024
Home
Patent No: 12,036,371 titled “Method of Accessing the Left Atrium with a Multi-Directional Steerable Catheter,”
News | EP Lab
BioCardia Announces United States Patent Issuance on Morph DNA Multi-Directional Steerable Catheter Transseptal Application

July 17, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...

Home July 17, 2024
Home
HHNM will use the Allia IGS Pulse system in its cardiac electrophysiology (EP) lab
News | EP Lab
Heart Hospital of New Mexico, GE HealthCare Collaborate to Install the First Allia IGS Pulse Electrophysiology Lab in the U.S. for Minimally Invasive Cardiovascular Procedures

June 25, 2024 — Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) and GE HealthCare (announced HHNM as the ...

Home June 25, 2024
Home
Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.
News | EP Lab
Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment

May 30, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced ...

Home May 30, 2024
Home
Stereotaxis will present an innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-quality cardiac ablation therapy in underserved regions of Africa
News | EP Lab
Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa

May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home May 21, 2024
Home
Latest digital platform provides key advancements to help maintain high signal fidelity while reducing environmental noise
News | EP Lab
GE HealthCare Announces Prucka 3 Digital Amplifier as Next Generation Platform for Electrophysiology Innovation

February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...

Home February 02, 2024
Home
It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of the passing of Bruce Wilkoff, MD, FHRS
News | EP Lab
In Memoriam: Bruce Wilkoff, MD, FHRS

January 11, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of ...

Home January 11, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now